A carregar...
Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
SIMPLE SUMMARY: Several clinical protocols are exploring the anticancer effect of immunotherapy combined to targeted therapy. Indeed, emerging evidence demonstrates that small-molecule targeted inhibitors promote the antitumor immune response. In the case of mechanistic target of rapamycin (mTOR) in...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002586/ https://ncbi.nlm.nih.gov/pubmed/33802831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061359 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|